# Computational fluid dynamics assessment of altered hemodynamics in the Circle of Willis during acute ischemic stroke and the impact of cerebral collateral development

**Authors:** Cody Kubicki, Scott Simon, Keefe B. Manning

PMC · DOI: 10.1007/s10237-026-02060-y · Biomechanics and Modeling in Mechanobiology · 2026-03-27

## TL;DR

This study uses a computational model to show how brain collaterals help during stroke by reducing pressure and improving blood flow.

## Contribution

A computational model is introduced to clarify how cerebral collaterals influence hemodynamics and treatment outcomes in stroke.

## Key findings

- Middle cerebral artery occlusion increases systemic mean arterial pressure by up to 30%.
- Well-developed collaterals reduce pressure drop across the clot by up to 66%.
- Ipsilateral collateral flow increases up to 20-fold following occlusion.

## Abstract

Cerebral collateral assessment has become a common metric for treatment planning in acute ischemic stroke patients due to clinical evidence that well-developed collateral networks are correlated with favorable patient outcomes for reperfusion therapies, such as intravenous thrombolytics and mechanical thrombectomy. However, the mechanisms driving these outcome disparities are not well clarified. In the present study, a computational model is used to help clarify these mechanisms by assessing the Circle of Willis hemodynamics during middle cerebral artery occlusion with different levels of collateral development present. The results showed that middle cerebral artery occlusion causes up to a 30% increase in systemic mean arterial pressure, but the increase is less severe in cases with better collateralization, and cases with well-developed collaterals had up to a 66% lower pressure drop across the clot compared to the cases with poor collateral development. The ipsilateral collateral flow increased up to 20-fold following occlusion, which elevated blood flow and mixing distal to the occlusion. These results indicate that cerebral collaterals serve multiple functions that are important to consider in stroke cases. First, collaterals compensate for part of the lost blood flow to the affected brain region by permitting retrograde flow toward the distal end of the occluded vessel. Second, collaterals reduce the pressure forces on the clot, which can improve the susceptibility to reperfusion therapies. Overall, this study shows that we can leverage our unique computational model to better understand the importance of cerebral collateral circulation during stroke and the influence of collaterals on therapeutic outcomes.

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, CEBPZ (CCAAT enhancer binding protein zeta) [NCBI Gene 10153] {aka CBF, CBF2, HSP-CBF, NOC1}, MYOZ2 (myozenin 2) [NCBI Gene 51778] {aka C4orf5, CMH16, CS-1, FATZ-2}, MYOZ3 (myozenin 3) [NCBI Gene 91977] {aka CS-3, CS3, FATZ-3, FRP3}, SSBP1 (single stranded DNA binding protein 1) [NCBI Gene 6742] {aka Mt-SSB, OPA13, SOSS-B1, SSBP, mtSSB}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, CSH2 (chorionic somatomammotropin hormone 2) [NCBI Gene 1443] {aka CS-2, CSB, GHB1, PL, hCS-B}
- **Diseases:** SCA (MESH:D013478), AIS (MESH:D000083242), clot (MESH:D013927), fracture (MESH:D050723), hypertension (MESH:D006973), Posterior Cerebral Artery (MESH:D020762), Artery (MESH:D012078), LCN (MESH:D008577), brain tissue damage (MESH:D017695), ischemic (MESH:D002545), LMCA occlusion (MESH:D001157), LVO (MESH:C536223), diabetes (MESH:D003920), hypoplastic (MESH:D000741), vessel stenosis (MESH:D003251), systole (MESH:D000092244), heart disease (MESH:D006331), infarct (MESH:D007238), stroke (MESH:D020521), brain infarct (MESH:D020520), MCA occlusion (MESH:D020244), CFD (MESH:C563256), Cerebral Artery (MESH:D002539), CoW (MESH:C536991), ischemic stroke (MESH:D002544), embolic stroke (MESH:D000083262), intracranial bleeding (MESH:D013345)
- **Chemicals:** AComA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A1 ACA

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13021737/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13021737/full.md

---
Source: https://tomesphere.com/paper/PMC13021737